Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00001506
Status:
RECRUITING
Last Update Posted:
2024-07-01
First Post:
1999-11-03
Brief Title:
Evaluation and Treatment of Patients With Dermatologic Diseases
Sponsor:
National Institute of Arthritis and Musculoskeletal and Skin Diseases NIAMS
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Evaluation and Treatment of Subjects With Dermatologic Diseases
Status:
RECRUITING
Status Verified Date:
2024-05-14
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a training natural history of disease and screening protocol for the evaluation treatment and follow-up of patients with dermatologic diseases and systemic diseases with cutaneous manifestations Patients enrolled in this protocol will be evaluated and treated according to generally available standard procedures and therapeutic modalities Samples of blood and skin will be studied by routine and specialized investigative methods to establish these patients diagnosis response to treatment andor disease progression
Detailed Description:
Background
This is a training natural history of disease and screening protocol for the evaluation treatment and follow-up of patients with dermatologic diseases and systemic diseases with cutaneous manifestations This protocol was developed to allow subject enrollment for teaching purposes and to allow for second opinions regarding relatively complicated patients and to allow for evaluation of non-invasive tools for the diagnosis and monitoring of cutaneous manifestations This protocol promotes a critical link between the NCI CCR Dermatology Branch and the local and national extramural medical communities
Objectives
To provide clinical material to fulfill the educational mission of the Dermatology Branch
To learn about the natural history of selected dermatologic diseases
Eligibility
All subjects regardless of age gender or racialethnic group with dermatologic disease or systemic disease with cutaneous manifestations
Design
Patients enrolled in this protocol will be evaluated and treated according to generally available standard procedures and therapeutic modalities Samples of blood and skin will be studied by routine and specialized investigative methods to establish these patients diagnosis response to treatment andor disease progression Non-invasive tools may be used as part of the examination and assessment of cutaneous manifestations of disease
This is a training natural history of disease and screening protocol for the evaluation treatment and follow-up of patients with dermatologic diseases and systemic diseases with cutaneous manifestations This protocol was developed to allow subject enrollment for teaching purposes and to allow for second opinions regarding relatively complicated patients and to allow for evaluation of non-invasive tools for the diagnosis and monitoring of cutaneous manifestations This protocol promotes a critical link between the NCI CCR Dermatology Branch and the local and national extramural medical communities
Objectives
To provide clinical material to fulfill the educational mission of the Dermatology Branch
To learn about the natural history of selected dermatologic diseases
Eligibility
All subjects regardless of age gender or racialethnic group with dermatologic disease or systemic disease with cutaneous manifestations
Design
Patients enrolled in this protocol will be evaluated and treated according to generally available standard procedures and therapeutic modalities Samples of blood and skin will be studied by routine and specialized investigative methods to establish these patients diagnosis response to treatment andor disease progression Non-invasive tools may be used as part of the examination and assessment of cutaneous manifestations of disease
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 96-AR-0102 | None | None | None |